G. Bureau

Medicine · Health Sciences

19h-index1.8kcitations66works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(37), Lung Cancer Research Studies(32), Neuroendocrine Tumor Research Advances(17), Lung Cancer Diagnosis and Treatment(11), Cancer therapeutics and mechanisms(9)

Publications66 total

Courrier des lecteurs
2020
Présentation
Revue Quart Monde·2020Open Access
Le travail partagé
2016
Hors-jeu ?
Revue Quart Monde·2015Open Access
Connaître, comprendre et agir
2011
Prognostic factors for patients with small cell lung cancer: Analysis of a series of 763 patients with a minimal 5 years follow-up duration
Lung Cancer·2000· 1 cited
Prognostic factors for patients with small cell lung carcinoma
Cancer·2000· 220 cited
Prognostic factor for patients with small cell lung cancer.
2000· 1 cited
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
European Journal of Cancer·1999· 29 cited
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy
Annals of Oncology·1999· 36 citedOpen Access
Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·1999· 4 cited
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy
Lung Cancer·1998· 14 cited
Is chemosensitivity a predictive factor for radiosensitivity in non-small cell lung cancer? Lesson from European Lung Cancer working party phase III randomised trial
Lung Cancer·1998
A phase III randomized study comparing, in non-metastatic unresectable non-small cell lung cancer (NSCLC) responding to chemotherapy (CT), further CT to loco-regional irradiation (RT)
Lung Cancer·1998· 2 cited
J'aimais la beauté de son geste...
1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Journal of Clinical Oncology·1998· 30 cited
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
PubMed·1997· 9 cited
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party
European Journal of Cancer·1997· 83 cited
880 Proposal of a more discriminant TNM stage grouping in patients with clinical stage III non small cell lung cancer (NSCLC) treated by primary chemotherapy
Lung Cancer·1997
161 Carboplatin prescribed in mg/m2 in patients with advanced non small cell lung cancer (NSCLC): Is there an impact of the reached area under the curve (AUC) on response, survival and hematological toxicity?
Lung Cancer·1997· 4 cited
page 1 of 4Next →

Frequent Co-authors

J Thiriaux(35), Jean Klášterský(35), P. Mommen(26), Marianne Paesmans(25), P Libert(23), G Dabouis(22), Jean‐Paul Sculier(21), O Van Cutsem(20), R Sergysels(18), M.C. Berchier(18), V. Giner(17), J. Lecomte(11), Vincent Ninane(11), J.P. Sculier(10), J. Michel(8), G. Vandermoten(8), P Ravez(7), M Paesmans(7), J Schmerber(7), Sculier Jp(7)